The Influence of Cardiovascular Diseases on the Diagnosis and Treatment of Anxiety Disorders: A Retrospective Study
- 1. Associate Professor, Department of Chest & Tuberculosis, Anugraha Narayan Medical College and Hospital, Gaya, Bihar
- 2. Assistant Professor, Department of Psychiatry, Mahatma Gandhi Medical College and Hospital, Tatanagar, Jharkhand
- 3. Assistant Professor, Department of Psychiatry, Sheikh Bhikari Medical college and hospital Hazaribagh , Jharkhand
Description
Background: Anxiety and heart disease are now known to be related to health problems. On the other hand, more study needs to be done to fully understand how cardiovascular diseases affect and how anxiety disorders are found and treated. Such understanding is necessary to enhance patient care and outcomes. Objectives: Anxiety disorder diagnosis and therapy may be affected by heart disease and other cardiovascular risk factors, making a retrospective study essential. The primary objective of this research was to assess the impact of co-occurring anxiety disorders on cardiovascular and medical outcomes. Secondary objectives included estimating the prevalence of anxiety disorders among people with cardiovascular diseases and identifying potential risk factors related to comorbidity. Method: This retrospective study used electronic health data to look at the medical histories of 200 persons who had been diagnosed with cardiovascular disease. By looking at diagnosis codes and patient medical records, we were able to calculate the prevalence of anxiety disorders in the population we were studying. Logistic regression analysis was used to identify demographic and clinical characteristics associated with the development of co-occurring anxiety disorders. The effect of comorbid anxiety disorders on hospitalisation rates and other cardiology-related outcomes was also examined using chi-square analyses. Results: The study revealed that nearly 60% of individuals with cardiovascular issues also have anxiety disorders. Age (p 0.05), comorbid disorders (p 0.05), and gender (p > 0.05) were all associated with an increased likelihood of co-occurring anxiety disorders, according to logistic regression analysis. 75% of participants with concurrent anxiety disorders were hospitalised, compared to 25% of participants without anxiety disorders (p 0.05). Conclusion: This retrospective study demonstrates how substantially cardiovascular issues affect the identification and treatment of anxiety disorders. The prevalence of anxiety disorders among individuals with cardiovascular diseases reflects the importance of mental health screening in this population. According to the findings, age and co-occurring conditions play a significant influence in the development of comorbid anxiety disorders. Higher hospitalisation rates among individuals with both forms of anxiety disorders indicate the need for interdisciplinary treatment approaches. To enhance outcomes for this group, researchers must investigate the underlying causes and determine how to treat them.
Abstract (English)
Background: Anxiety and heart disease are now known to be related to health problems. On the other hand, more study needs to be done to fully understand how cardiovascular diseases affect and how anxiety disorders are found and treated. Such understanding is necessary to enhance patient care and outcomes. Objectives: Anxiety disorder diagnosis and therapy may be affected by heart disease and other cardiovascular risk factors, making a retrospective study essential. The primary objective of this research was to assess the impact of co-occurring anxiety disorders on cardiovascular and medical outcomes. Secondary objectives included estimating the prevalence of anxiety disorders among people with cardiovascular diseases and identifying potential risk factors related to comorbidity. Method: This retrospective study used electronic health data to look at the medical histories of 200 persons who had been diagnosed with cardiovascular disease. By looking at diagnosis codes and patient medical records, we were able to calculate the prevalence of anxiety disorders in the population we were studying. Logistic regression analysis was used to identify demographic and clinical characteristics associated with the development of co-occurring anxiety disorders. The effect of comorbid anxiety disorders on hospitalisation rates and other cardiology-related outcomes was also examined using chi-square analyses. Results: The study revealed that nearly 60% of individuals with cardiovascular issues also have anxiety disorders. Age (p 0.05), comorbid disorders (p 0.05), and gender (p > 0.05) were all associated with an increased likelihood of co-occurring anxiety disorders, according to logistic regression analysis. 75% of participants with concurrent anxiety disorders were hospitalised, compared to 25% of participants without anxiety disorders (p 0.05). Conclusion: This retrospective study demonstrates how substantially cardiovascular issues affect the identification and treatment of anxiety disorders. The prevalence of anxiety disorders among individuals with cardiovascular diseases reflects the importance of mental health screening in this population. According to the findings, age and co-occurring conditions play a significant influence in the development of comorbid anxiety disorders. Higher hospitalisation rates among individuals with both forms of anxiety disorders indicate the need for interdisciplinary treatment approaches. To enhance outcomes for this group, researchers must investigate the underlying causes and determine how to treat them.
Files
IJPCR,Vol15,Issue7,Article42.pdf
Files
(532.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:411626c85669a914cc8ea97e85d1cc3c
|
532.9 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-05-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue7,Article42.pdf
- Development Status
- Active
References
- 1. S. Guillaumontet al., Diagnosis of isolated right aortic arch: Accuracy of prenatal diagnosis, associated genomic disorders and interest of systematic postnatal imaging. the arcade multicentre retrospective observational study, Archives of Cardiovascular Diseases Supplements, 2022; 14:3–4: 219. 2. B. Liang, Y. Qu, Q.-F. Zhao, and N. Gu, Guanxin V for coronary artery disease: A retrospective study, Biomedicine &; Pharmacotherapy, 2020; 128:110280. 3. J. E. Sanner Beauchamp et al., A retrospective study to identify novel factors associated with post-stroke anxiety, Journal of Stroke and Cerebrovascular Diseases, 2020; 29(2): 104582. 4. F. K. Ho et al., Child maltreatment and cardiovascular disease: Quantifying mediation pathways using UK Biobank, BMC Medicine, 2020; 18(1). 5. H. R. Karlsen, F. Matejschek, I. SaksvikLehouillier, and E. Langvik, Anxiety as a risk factor for cardiovascular disease independent of depression: A narrative review of current status and conflicting findings, Health Psychology Open, 2021; 8(1): 205510292098746. 6. D. C. Gümbelet al., "Association between syncope and the 6-month incidence of ischemic stroke, arrhythmia, brain tumor, epilepsy, and anxiety disorder," Healthcare, 2023; 11(13): 1913. 7. N. Moulson et al., Rationale and design of the ORCCA (outcomes registry for cardiac conditions in athletes) study, Journal of the American Heart Association, 2023; 12:11.8. R. E. Nielsen, J. Banner, and S. E. Jensen, Cardiovascular disease in patients with severe mental illness, Nature Reviews Cardiology, 2020; 18(2): 136–145. 9. R. C. Monahan et al., Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: A retrospective analysis from a tertiary referral center in the Netherlands, Lupus, 2020; 29(14):1892–1901. 10. L. M. Behlke, E. J. Lenze, and R. M. Carney, The cardiovascular effects of newer antidepressants in older adults and those with or at high risk for cardiovascular diseases, CNS Drugs, 2020; 34(11): 1133–1147. 11. S. Kulkarni, R. Rao, J. D. Goodman, K. Connolly, and K. M. O'Shaughnessy, Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension, Medicine, 2021; 100:14. 12. P. Kushalnagar, C. Ryan, R. Paludneviciene, A. Spellun, and S. Gulati, Adverse childhood communication experiences associated with an increased risk of chronic diseases in adults who are deaf, American Journal of Preventive Medicine, 2020; 59:4:548–554. 13. K. Mitra, A. R. Bhuiyan, and E. A. Jones, "Association and risk factors for obstructive sleep apnea and cardiovascular diseases: A systematic review, Diseases, 2021; 9(4): 88. 14. L.-F. Lim, M. Solmi, and S. Cortese, Association between anxiety and hypertension in adults: A systematic review and meta-analysis, Neuroscience & Biobehavioral Reviews, 2021; 131:96–119. 15. T. Nakamura et al., Orexin receptor antagonists versus antipsychotics for the management of delirium in intensive care unit patients with cardiovascular disease: A retrospective observational study, General Hospital Psychiatry, 2023; 84:96–101.